4baseCare
Precision oncology, accessible to every patient.
4baseCare is a precision oncology company that has innovated a South-Asian panel for genetic tests, with genomic testing solutions tailored to South Asian populations. It combines next-generation sequencing with clinical interpretation to help oncologists match patients to targeted therapies based on individual genetic profiles. Its diagnostic panels and reporting tools are used by hospitals, cancer centres, and treating physicians across India and international markets. By building genomic reference data specific to the region, the company addresses a gap left by Western-centric datasets, operating at the intersection of diagnostics, genomics, and personalised cancer care.
Precision oncology in India needs founders who can hold clinical rigour and software velocity in the same head. Hitesh and Kshitij do — and their refusal to treat the South Asian genome as an afterthought is why we believe 4baseCare can define this category for emerging markets. What convinced us most was how deeply the team had thought about the oncologist's workflow, not just the science: the reports, the turnaround times, the tumour boards, the tough conversations with families. That empathy — combined with genuine research depth — is a rare compounding moat, and one we wanted to back for the long arc.
- 01
Proprietary South Asian cancer variant database
- 02
Software-led economics layered on regulated diagnostics
- 03
Clinical co-founders with global oncology relationships
"MJV didn't just write a cheque — they sat with us through the hardest hiring and partnership decisions."
Building in the same category?
Pitch us →